CSPC Pharmaceutical Group Statistics
Total Valuation
CSPCY has a market cap or net worth of 14.31 billion. The enterprise value is 13.25 billion.
| Market Cap | 14.31B |
| Enterprise Value | 13.25B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Oct 20, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.93% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 25.42% |
| Owned by Institutions (%) | 27.20% |
| Float | 7.77B |
Valuation Ratios
The trailing PE ratio is 25.08 and the forward PE ratio is 17.60.
| PE Ratio | 25.08 |
| Forward PE | 17.60 |
| PS Ratio | 3.89 |
| PB Ratio | 2.92 |
| P/TBV Ratio | 3.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 23.22 |
| EV / Sales | 3.61 |
| EV / EBITDA | 17.10 |
| EV / EBIT | 22.74 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | n/a |
| Interest Coverage | 99.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.02% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 9.00% |
| Revenue Per Employee | 191,123 |
| Profits Per Employee | 29,611 |
| Employee Count | 19,266 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSPCY has paid 149.35 million in taxes.
| Income Tax | 149.35M |
| Effective Tax Rate | 20.70% |
Stock Price Statistics
The stock price has increased by +122.87% in the last 52 weeks. The beta is 0.87, so CSPCY's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +122.87% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 4.24 |
| Relative Strength Index (RSI) | 55.23 |
| Average Volume (20 Days) | 5,078 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPCY had revenue of 3.68 billion and earned 570.48 million in profits. Earnings per share was 0.05.
| Revenue | 3.68B |
| Gross Profit | 2.44B |
| Operating Income | 591.68M |
| Pretax Income | 721.39M |
| Net Income | 570.48M |
| EBITDA | 761.63M |
| EBIT | 591.68M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.36 billion in cash and 69.53 million in debt, with a net cash position of 1.29 billion.
| Cash & Cash Equivalents | 1.36B |
| Total Debt | 69.53M |
| Net Cash | 1.29B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.90B |
| Book Value Per Share | 0.41 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 66.23%, with operating and profit margins of 16.07% and 15.49%.
| Gross Margin | 66.23% |
| Operating Margin | 16.07% |
| Pretax Margin | 19.59% |
| Profit Margin | 15.49% |
| EBITDA Margin | 20.68% |
| EBIT Margin | 16.07% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.96%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 1.96% |
| Dividend Growth (YoY) | -20.07% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.93% |
| Shareholder Yield | 4.89% |
| Earnings Yield | 3.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 16, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Nov 16, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |